MedTrace Logo

480 Biomedical Bioresorbable Scaffold System in the Treatment of de Novo Superficial Femoral Artery (SFA) Lesions

NCT01403077 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2019-09-06

No results posted yet for this study

Summary

This is an initial evaluation of the 480 Biomedical Bioresorbable Scaffold System for the treatment of subjects with de novo native superficial femoral artery lesions.

Conditions

  • Superficial Femoral Artery Lesions
  • Atherosclerosis of Femoral Artery

Interventions

DEVICE

480 Biomedical Bioresorbable Scaffold System

480 Biomedical Bioresorbable Scaffold System

Sponsors & Collaborators

  • 480 Biomedical

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2014-03-31
Completion
2015-10-31

Countries

  • Australia
  • Austria
  • Germany
  • New Zealand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01403077 on ClinicalTrials.gov